Loading...
XHEL
TTALO
Market cap1.10bUSD
Jun 18, Last price  
7.54EUR
1D
2.59%
1Q
-17.69%
IPO
-25.79%
Name

Terveystalo Oyj

Chart & Performance

D1W1MN
XHEL:TTALO chart
P/E
13.34
P/S
0.71
EPS
0.57
Div Yield, %
6.37%
Shrs. gr., 5y
-0.11%
Rev. gr., 5y
5.39%
Revenues
1.28b
-4.56%
474,125,000505,619,000546,964,000689,500,000744,700,0001,030,700,000986,400,0001,154,600,0001,259,100,0001,286,400,0001,340,000,0001,278,900,000
Net income
93m
+29.15%
-82,897,0001,105,00012,606,0007,200,00068,700,00054,100,00045,800,00080,500,00024,400,000-42,200,00071,700,00092,600,000
CFO
187m
-16.32%
58,303,00059,932,00064,670,00070,000,000100,600,000173,600,000143,700,000195,200,000140,900,000158,000,000223,700,000187,200,000
Dividend
Oct 07, 20260.32 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Helsinki, Finland-based Terveystalo Oyj operates as a prominent healthcare service provider, with a core focus on occupational health within Finland. The company delivers a wide spectrum of medical services, encompassing general practitioner and specialized care, diagnostic tests, and outpatient surgery. Its offerings further extend to dental services, child welfare, and various wellness programs. Terveystalo also provides healthcare organizations with outsourcing and staffing solutions, alongside engaging in clinical research and offering extensive digital health services. Its clientele is broad, serving private individuals, businesses, communities, insurance companies, and the public sector. Founded in 2001, Terveystalo boasts a significant national footprint, managing 360 clinics – including 18 hospital facilities, 38 dental practices, and 73 Rela hierojat massage therapy units.
URL
https://www.terveystalo.com/
IPO date
Oct 11, 2017
Employees
10,094
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT